SlimSEB™. One Ingredient. Every Stage of the GLP-1 Journey.
Millions of people are using GLP-1 drugs. Millions more are coming off them. Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty price tags, concerned about side effects or simply unwilling to go the pharmaceutical route.
All of these consumers need support. Most of them aren’t getting it. SlimSEB™ is a blend of enzymes, probiotics and herbal extracts designed to support consumers’ biggest issues through each stage of the GLP-1 journey. It can even serve as an alternative, and i’s backed by clinical studies.
The Numbers Are Hard to Ignore
GLP-1 agonists have moved from niche to mainstream at remarkable speed. Roughly 23% of U.S. households now report using a GLP-1 drug and adoption continues to climb.
The downstream market impact is enormous. By 2030, GLP-1 households are expected to drive roughly 35% of all food and beverage sales. Meanwhile, 80% of GLP-1 users say they are willing to pay more for products with added health benefits.
Consumers are ready to spend and already primed to buy. The opportunity is massive, and many brands have yet to act.
The Overlooked Stage of the Journey: Post-GLP-1 Use
An important question is what happens after GLP-1 use ends. Because these drugs alter how digestion works, former users can find themselves navigating digestive and gut health issues along with very real anxiety about rebound weight gain.
The transition off GLP-1 therapy represents one of the biggest unmet needs in the weight-management journey today.
SlimSEB: Clinically Studied Metabolic Support
Whether you’re developing a GLP-1 companion product or a non-pharmaceutical alternative, SlimSEB™ provides a science-backed solution.

SlimSEB™ is a clinically studied blend of enzymes, probiotics and herbal extracts formulated to support metabolism on multiple levels simultaneously.*
- Supports healthy weight management with or without GLP-1 use*
- Promotes metabolic health, including healthy glucose & lipid profiles*
- Converts dietary sugars into short-chain fibers, supporting satiety & gut health*
- Modulates hunger hormone signaling*
- Promotes healthy cholesterol levels*
- Supports a healthy response to inflammation*
- Supports digestive health*
- Supports digestion & nutrient absorption during periods of reduced caloric intake*
- Supports gut health*
- Supports a healthy gut microbiome*
Clinical Study #1 | Metabolic and Weight Benefits
A recently completed clinical study demonstrated remarkable improvements across key weight, metabolic and cardiovascular markers.*
Participants supplementing with SlimSEB™ experienced:

Weight loss, improved blood sugar and healthier cholesterol levels, all from a single, clean-label formulation.
Three Opportunities. One Formulation.
One of SlimSEB™’s greatest advantages is its versatility. It supports three rapidly growing consumer segments, each actively looking for metabolic support.
- Post GLP-1 Use | Rebound Support
Transitioning off GLP-1 drugs is one of the most vulnerable moments in a weight management journey. Metabolic function is in flux, habits are still forming and without the right support, weight regain is common.
SlimSEB™ promotes metabolic balance and ongoing weight management during and after that transition, providing consumers with a research-backed option when they step down.*
- Alternative Path | Non-Pharmaceutical Option
Millions of consumers want to lose weight but won’t or can’t take GLP-1s. Cost, side effects, contraindications or a preference for natural solutions keep them out of the pharmaceutical lane.
For them, SlimSEB™ offers a clean-label solution that supports metabolic health and weight management without a prescription.*
- During GLP-1 Use | GLP-1 Companion
For consumers currently on GLP-1s, SlimSEB™ supports digestive comfort and promotes healthy metabolic markers during a period when caloric intake is dropping sharply. It’s the support system that helps users stay comfortable and stay on track.*
Clinical Study #2 | Support for Active GLP-1 Users
A second, recently completed clinical study evaluated adults actively using GLP-1 agonists.

SlimSEB™ promotes improved digestive comfort and additional weight loss for consumers who are already on GLP-1s and need support to stay there.*
The Opportunity for Brands
The GLP-1 consumer base isn’t peaking, it’s compounding. More consumers will begin the journey. More will transition off GLP-1s, or leave early, and need somewhere to land. More will search for alternatives.
Each of these moments is a formulation opportunity. Each one represents consumers actively searching for support, primed to spend and ready to trust products that show up with credible science behind them.
SlimSEB™ isn’t just another ingredient. It gives you the clinical backing and formulation flexibility to build products that support every phase of the GLP-1 journey:
- Companion
- Rebound
- Alternative
The market is moving fast. Consumer demand is already here. Brands that bring clinically studied solutions to market now won’t just capture share; they will help define the category.
Will you lead the charge?

Find Us at SupplySide Connect, Booth #242
We’ll be at SupplySide Connect on April 14–15, and we’d love to get into the details with you.
Stop by Booth #242 to meet our enzyme and probiotic experts, walk through the clinical data behind SlimSEB™ and explore how it fits your next product. Developing a GLP-1 companion, a post-therapy support product or a clean-label daily metabolic formula? We’ll help you find exactly where SlimSEB™ belongs.
Want to guarantee time with the team? Reach out now and lock in a meeting before the show. The consumer need is already here. Let’s work together to build the products to meet it.

Attend Our Weight Management & GLP-1 Support Webinar
And on Tuesday, April 28, at 11:30 AM ET, attend our webinar on weight management and GLP-1 support. Join Dr. Abhijit Rathi as he takes a deeper dive into the SlimSEB™ study results and discusses adjunct strategies to support weight management, metabolic health and gastrointestinal comfort.
Sources
- (2026, March 9).
- Cohen, J. P. (2026, January 12). Forbes.
- Sherman, A. (2025, May 27). NutraIngredients.com.
- Johnson, B., Milstead, M., Thomas, O., McGlasson, T., Green, L., Kreider, R., & Jones, R. (2025, April 25). Frontiers in nutrition.
- Goodwin Cartwright, MS, B., Rodriguez, PhD, MPH, P., Do, PhD, D., & Stucky, MD, PhD, N. (2026, March 12). Truveta.
- Rathi, A. et al. 2026. Advanced Enzymes proprietary clinical study.
- Rathi, A. et al. 2026. Advanced Enzymes proprietary clinical study.